“Monoclonal Antibody Against CGRP (TEV-48125) for Preventive Treatment of Episodic Cluster Headache: A Phase II Randomized Clinical Trial Protocol”. 2018. Principles and Practice of Clinical Research 4 (1): 14-20. https://journal.ppcr.org/index.php/ppcrjournal/article/view/53.